Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants
暂无分享,去创建一个
S. Miyano | Y. Shiraishi | K. Chiba | S. Ogawa | Y. Shiozawa | A. Sato-Otsubo | Kenichi Yoshida | H. Kato | T. Inamoto | A. Yamauchi | Y. Kataoka | M. Toi | Y. Fujii | Y. Nannya | H. Suwa | M. Torii | M. Takada | M. Kawashima | K. Yamagami | S. Tsuyuki | E. Suzuki | Hiroko Tanaka | T. Nishimura | N. Senda | Yukiko Inagaki-Kawata | H. Yoshibayashi | Y. Moriguchi | R. Okamura | Y. Takeuchi | Y. Inoue | N. Kawaguchi‐Sakita
[1] Benjamin L. Ebert,et al. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes , 2019, Nature Medicine.
[2] N. Socci,et al. Tumour lineage shapes BRCA-mediated phenotypes , 2019, Nature.
[3] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[4] Y. Kamatani,et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls , 2018, Nature Communications.
[5] Paul Ellis,et al. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial , 2018, Nature Medicine.
[6] Nancy R. Zhang,et al. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers , 2017, Nature Communications.
[7] E. Lander,et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer , 2017, Nature Genetics.
[8] Yuntao Xie,et al. Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients , 2017, Clinical Cancer Research.
[9] M. Robson,et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation , 2017, The New England journal of medicine.
[10] John Kidd,et al. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] F. Nielsen,et al. Hereditary breast and ovarian cancer: new genes in confined pathways , 2016, Nature Reviews Cancer.
[12] Ahmet Zehir,et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. , 2016, The New England journal of medicine.
[13] Satoru Miyano,et al. Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers , 2016, Nature.
[14] David C. Jones,et al. Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.
[15] Fengxia Xiao,et al. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients , 2016, Oncotarget.
[16] Li Ding,et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.
[17] Y. Miki,et al. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan , 2015, Breast Cancer.
[18] Nazneen Rahman,et al. Gene-panel sequencing and the prediction of breast-cancer risk. , 2015, The New England journal of medicine.
[19] M. Stephens,et al. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures , 2015, bioRxiv.
[20] Brigitte Rack,et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] D. Pe’er,et al. Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers , 2014, Cell.
[22] Nazneen Rahman,et al. Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.
[23] S. Miyano,et al. The landscape of somatic mutations in Down syndrome–related myeloid disorders , 2013, Nature Genetics.
[24] H. Kume,et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data , 2013, Nucleic acids research.
[25] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[26] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[27] A. Sivachenko,et al. Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.
[28] M. Gönen,et al. Evolutionary pathways in BRCA1-associated breast tumors. , 2012, Cancer discovery.
[29] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[30] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[31] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[32] Tatiana Popova,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.
[33] Hiroyuki Konishi,et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells , 2011, Proceedings of the National Academy of Sciences.
[34] Y. Drew,et al. Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2. , 2011, Journal of the National Cancer Institute.
[35] Ashok R Venkitaraman,et al. Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. , 2010, Cancer cell.
[36] M. Rivas,et al. Nature Genetics Advance Online Publication High-throughput, Pooled Sequencing Identifies Mutations in Nubpl and Foxred1 in Human Complex I Deficiency , 2022 .
[37] Y. Miki,et al. Cross‐sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer , 2008, Cancer science.
[38] Motohiro Kato,et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.
[39] Shigeru Chiba,et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.
[40] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[41] William D. Foulkes,et al. Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .
[42] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Tsuji,et al. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.